(1, 10B-dihydro-2-(aminoalkylphenyl)-5H-pyrazolo [1,5-c] [1,3] benzoxazin-5-yl) phenyl methanone derivatives as HIV viral replication inhibitors

Details for Australian Patent Application No. 2006233922 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Hu, Lili; Surleraux, Dominique Louis Nestor Ghislain; Wigerinck, Piet Tom Bert Paul; Tahri, Abdellah

Agent Shelston IP

Pub. Number AU-B-2006233922

PCT Pub. Number WO2006/108828

Priority 05102847.0 11.04.05 EP

Filing date 11 April 2006

Wipo publication date 19 October 2006

Acceptance publication date 17 May 2012

International Classifications

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/5365 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/108828 Priority application(s): WO2006/108828

8 November 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read (1, 10B-dihydro-2-(aminoalkylphenyl)-5H-pyrazolo [1,5-c] [1,3] benzoxazin-5-yl) phenyl methanone derivatives as HIV viral replication inhibitors

17 May 2012 Application Accepted

  Published as AU-B-2006233922

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006233927-Molecules and methods of using same for treating mcp-1/ccr2 associated diseases

2006233918-Infant formula with probiotics